Read this company snapshot
Daily valuation snapshot
Alpha Tau Medical Ltd. Ordinary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $14.41
- Market capitalization (USD)
- $1,332,610,199.14
- Price / earnings (TTM)
- Not reported
- Price / book
- 17.28
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research DRTS in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research DRTS in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing DRTS with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $14.41 |
| Market capitalization (USD) | $1,332,610,199.14 |
| Price / earnings (TTM) | Not reported |
| Price / book | 17.28 |
No matching rows. Clear the filter to see all records.
Read DRTS's valuation metrics
Company size
Alpha Tau Medical Ltd. Ordinary Shares's recorded market capitalization is $1,332,610,199.14. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
DRTS's recorded price-to-book ratio is 17.28. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Alpha Tau Medical Ltd. Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about DRTS. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow DRTS's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.